A business in context
NBIX research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-05-27 | MORROW GEORGE J | A · Grant / award | Restriced Stock Unit | 2567.0 | 0.0 |
| 2026-05-26 | Boyer David W. | S · Sale | Common Stock | 3888.0 | 156.64 |
| 2026-05-21 | Mercier Johanna | M · Exercise / conversion | Common Stock | 3318.0 | 0.0 |
| 2026-05-21 | Mercier Johanna | M · Exercise / conversion | Restricted Stock Unit | 3318.0 | 0.0 |
| 2026-05-21 | Norwalk Leslie V | M · Exercise / conversion | Common Stock | 1659.0 | 0.0 |
| 2026-05-21 | Norwalk Leslie V | M · Exercise / conversion | Restricted Stock Unit | 1659.0 | 0.0 |
| 2026-05-21 | Sharp Shalini | M · Exercise / conversion | Common Stock | 1659.0 | 0.0 |
| 2026-05-21 | Sharp Shalini | M · Exercise / conversion | Restricted Stock Unit | 1659.0 | 0.0 |
| 2026-05-21 | RASTETTER WILLIAM H | M · Exercise / conversion | Common Stock | 3318.0 | 0.0 |
| 2026-05-21 | RASTETTER WILLIAM H | M · Exercise / conversion | Restricted Stock Unit | 3318.0 | 0.0 |
| 2026-05-21 | POON CHRISTINE A | M · Exercise / conversion | Common Stock | 3318.0 | 0.0 |
| 2026-05-21 | POON CHRISTINE A | M · Exercise / conversion | Restricted Stock Unit | 3318.0 | 0.0 |
| 2026-05-21 | POPS RICHARD F | M · Exercise / conversion | Common Stock | 3318.0 | 0.0 |
| 2026-05-21 | POPS RICHARD F | M · Exercise / conversion | Restricted Stock Unit | 3318.0 | 0.0 |
| 2026-05-21 | LYONS GARY A | M · Exercise / conversion | Common Stock | 1659.0 | 0.0 |
| 2026-05-21 | LYONS GARY A | M · Exercise / conversion | Restricted Stock Unit | 1659.0 | 0.0 |
| 2026-05-21 | SHERWIN STEPHEN A | M · Exercise / conversion | Common Stock | 3318.0 | 0.0 |
| 2026-05-21 | SHERWIN STEPHEN A | M · Exercise / conversion | Restricted Stock Unit | 3318.0 | 0.0 |
| 2026-05-21 | MORROW GEORGE J | M · Exercise / conversion | Common Stock | 3318.0 | 0.0 |
| 2026-05-21 | MORROW GEORGE J | M · Exercise / conversion | Restricted Stock Unit | 3318.0 | 0.0 |
| 2026-05-19 | GORMAN KEVIN CHARLES | M · Exercise / conversion | Common Stock | 205088.0 | 43.24 |
| 2026-05-19 | GORMAN KEVIN CHARLES | S · Sale | Common Stock | 245088.0 | 154.33 |
| 2026-05-19 | GORMAN KEVIN CHARLES | M · Exercise / conversion | Non-Qualified Stock Option | 205088.0 | 0.0 |
| 2026-05-15 | POPS RICHARD F | S · Sale | Common Stock | 15000.0 | 157.65 |
| 2026-05-15 | POPS RICHARD F | M · Exercise / conversion | Common Stock | 15000.0 | 47.89 |
| 2026-05-15 | POPS RICHARD F | M · Exercise / conversion | Non-Qualified Stock Option | 15000.0 | 0.0 |
| 2026-05-12 | Norwalk Leslie V | S · Sale | Common Stock | 3810.0 | 155.01 |
Identity & relationships
SEC issuer · 0000914475NEUROCRINE BIOSCIENCES INC
- Legal Entity Identifier
- 549300FECER0XBN49756
- GLEIF legal name
- Neurocrine Biosciences, Inc.
- Entity / LEI registration status
- ACTIVE / LAPSED
- Reference data updated
- 2026-07-29T18:14:48Z
Search names and former names
View Wikidata identity and references ↗
- Neurocrine Biosciences · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $2.36B | $2.51B |
| 2023-12-31 | $1.89B | $2.07B |
| 2022-12-31 | $1.49B | $1.70B |
| 2021-12-31 | $1.13B | $1.40B |
| 2020-12-31 | $1.05B | $1.35B |
| 2019-12-31 | $788.10M | $1.03B |
| 2018-12-31 | $451.20M | $599.97M |
| 2017-12-31 | $161.63M | $220.17M |